Literature DB >> 8956331

Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.

K Tamura1, C P Lee, P L Smith, R T Borchardt.   

Abstract

PURPOSE: The purpose of this study was to determine the stereospecificity of the apical oligopeptide transporter(s) for the stereoisomers of Val-Val-Val and to determine whether the interaction of these molecules with this transporter(s) could be correlated with their cellular uptake and/or transepithelial transport.
METHODS: The interactions of these stereoisomers with this transporter(s) were evaluated by determining their ability to inhibit [3H]cephalexin uptake into Caco-2 cells. The metabolism of these stereoisomers was determined in a homogenate of Caco-2 cells and in the apical bathing solution over Caco-2 cell monolayers. The cellular uptake and transepithelial transport properties of these stereoisomers were studied using the Caco-2 cell monolayers.
RESULTS: The L-L-L tripeptide was totally degraded within 1 h in the Caco-2 cell homogenate and within 2 h when applied to the apical side of a Caco-2 cell monolayer. In contrast, 36.7 +/- 1.3% and 69.7 +/- 0.9% of L-Val-L-Val-D-Val remained after 2 h in the cell homogenate and in the apical bathing solution, respectively. The other six stereoisomers of Val-Val-Val were completely stable in the Caco-2 cell homogenate. Five of the stereoisomers (L-L-L, L-L-D, L-D-L, D-L-L, D-D-L) significantly inhibited the cellular uptake of [3H]cephalexin (91%, 62%, 14%, 45%, 16%, respectively). The other stereoisomers had no effect on the [3H]cephalexin uptake. When the cellular uptake of the stereoisomers was determined, the D-L-L and L-D-L tripeptides showed the highest intracellular concentrations (1.32 +/- 0.25 and 0.62 +/- 0.20 nmol/mg protein after a 2-h incubation, respectively). In contrast, the intracellular concentrations of the other stereoisomers were less than 0.1 nmol/mg protein. Moreover, the cellular uptake of the D-L-L and L-D-L tripeptides was inhibited by Gly-Pro by 82% and 68%, respectively, whereas Gly-Pro showed moderate to no inhibitory effect on the cellular uptake of the other stereoisomers. The permeability coefficients of the stereoisomers across the Caco-2 cell monolayers were very low (1.8 to 3.1 x 10(-7) cm/sec) and almost identical. Gly-Pro had no effect on their transepithelial transport.
CONCLUSIONS: These results suggest that the interaction of the Val-Val-Val stereoisomers with the apical oligopeptide transporter(s) could be a good predictor of their cellular uptake. However, since the major transepithelial transport mechanism of Val-Val-Val stereoisomers is passive diffusion via the paracellular route, the binding of these molecules to the oligopeptide transporter(s) is not a good predictor of their transepithelial transport. It appears that the stereochemical requirements for the transporter that mediates permeation of the peptide across the basolateral membrane may be different from the requirements for the apical transporter that mediates cellular uptake.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956331     DOI: 10.1023/a:1016436606183

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  A survey of membrane peptidases in two human colonic cell lines, Caco-2 and HT-29.

Authors:  S Howell; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

2.  Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.

Authors:  A R Hilgers; R A Conradi; P S Burton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

3.  Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption.

Authors:  W Rubas; N Jezyk; G M Grass
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

4.  Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril.

Authors:  D I Friedman; G L Amidon
Journal:  Pharm Res       Date:  1989-12       Impact factor: 4.200

5.  Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans.

Authors:  B H Stewart; O H Chan; R H Lu; E L Reyner; H L Schmid; H W Hamilton; B A Steinbaugh; M D Taylor
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

6.  A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa.

Authors:  D C Kim; P S Burton; R T Borchardt
Journal:  Pharm Res       Date:  1993-12       Impact factor: 4.200

7.  Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes.

Authors:  D T Thwaites; C D Brown; B H Hirst; N L Simmons
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

8.  Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2.

Authors:  H Saito; K Inui
Journal:  Am J Physiol       Date:  1993-08

9.  Transport and metabolism of delta sleep-inducing peptide in cultured human intestinal epithelial cell monolayers.

Authors:  P F Augustijns; R T Borchardt
Journal:  Drug Metab Dispos       Date:  1995-12       Impact factor: 3.922

10.  Transcellular transport of oral cephalosporins in human intestinal epithelial cells, Caco-2: interaction with dipeptide transport systems in apical and basolateral membranes.

Authors:  S Matsumoto; H Saito; K Inui
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

View more
  4 in total

1.  Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells.

Authors:  N J Snyder; L B Tabas; D M Berry; D C Duckworth; D O Spry; A H Dantzig
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 2.  Prodrug strategies in ocular drug delivery.

Authors:  Megha Barot; Mahuya Bagui; Mitan R Gokulgandhi; Ashim K Mitra
Journal:  Med Chem       Date:  2012-07       Impact factor: 2.745

3.  A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.

Authors:  J Gao; O Murase; R L Schowen; J Aubé; R T Borchardt
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

4.  Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis.

Authors:  Balvinder S Vig; Philip J Lorenzi; Sachin Mittal; Christopher P Landowski; Ho-Chul Shin; Henry I Mosberg; John M Hilfinger; Gordon L Amidon
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.